0000899243-18-004193.txt : 20180215 0000899243-18-004193.hdr.sgml : 20180215 20180215164956 ACCESSION NUMBER: 0000899243-18-004193 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20180213 FILED AS OF DATE: 20180215 DATE AS OF CHANGE: 20180215 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Canaan VIII LP CENTRAL INDEX KEY: 0001419148 STATE OF INCORPORATION: E9 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38386 FILM NUMBER: 18618334 BUSINESS ADDRESS: STREET 1: 285 RIVERSIDE AVE STREET 2: STE 250 CITY: WESTPORT STATE: CT ZIP: 06880 BUSINESS PHONE: 203-855-0400 MAIL ADDRESS: STREET 1: 285 RIVERSIDE AVE STREET 2: STE 250 CITY: WESTPORT STATE: CT ZIP: 06880 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Canaan Partners VIII LLC CENTRAL INDEX KEY: 0001552200 STATE OF INCORPORATION: E9 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38386 FILM NUMBER: 18618333 BUSINESS ADDRESS: STREET 1: 285 RIVERSIDE AVE STREET 2: STE 250 CITY: WESTPORT STATE: CT ZIP: 06880 BUSINESS PHONE: 203-855-0400 MAIL ADDRESS: STREET 1: 285 RIVERSIDE AVE STREET 2: STE 250 CITY: WESTPORT STATE: CT ZIP: 06880 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Cardlytics, Inc. CENTRAL INDEX KEY: 0001666071 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMPUTER PROGRAMMING, DATA PROCESSING, ETC. [7370] IRS NUMBER: 263039436 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 675 PONCE DE LEON AVENUE, NE STREET 2: SUITE 6000 CITY: ATLANTA STATE: GA ZIP: 30308 BUSINESS PHONE: 888-795-5802 MAIL ADDRESS: STREET 1: 675 PONCE DE LEON AVENUE, NE STREET 2: SUITE 6000 CITY: ATLANTA STATE: GA ZIP: 30308 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2018-02-13 0 0001666071 Cardlytics, Inc. CDLX 0001419148 Canaan VIII LP C/O CANAAN PARTNERS 285 RIVERSIDE AVENUE, SUITE 250 WESTPORT CT 06880 1 0 1 0 0001552200 Canaan Partners VIII LLC 285 RIVERSIDE AVENUE, SUITE 250 WESTPORT CT 06880 1 0 1 0 Common Stock 2018-02-13 4 C 0 3245364 0.00 A 3245364 D Series A-R Redeemable Convertible Preferred Stock 0.00 2018-02-13 4 C 0 950000 0.00 D Common Stock 950000 0 D Series B-R Redeemable Convertible Preferred Stock 0.00 2018-02-13 4 C 0 1145953 0.00 D Common Stock 1145953 0 D Series C-R Redeemable Convertible Preferred Stock 0.00 2018-02-13 4 C 0 514023 0.00 D Common Stock 514023 0 D Series D-R Redeemable Convertible Preferred Stock 0.00 2018-02-13 4 C 0 202377 0.00 D Common Stock 202377 0 D Series E-R Redeemable Convertible Preferred Stock 0.00 2018-02-13 4 C 0 119254 0.00 D Common Stock 119254 0 D Series G Redeemable Convertible Preferred Stock 0.00 2018-02-13 4 C 0 53660 0.00 D Common Stock 53660 0 D Series G' Redeemable Convertible Preferred Stock 0.00 2018-02-13 4 C 0 260097 0.00 D Common Stock 260097 0 D Each share of the Issuer's Series A-R Redeemable Convertible Preferred Stock, Series B-R Redeemable Convertible Preferred Stock, Series C-R Redeemable Convertible Preferred Stock, Series D-R Redeemable Convertible Preferred Stock, Series E-R Redeemable Convertible Preferred Stock, Series G Redeemable Convertible Preferred Stock and Series G' Redeemable Convertible Preferred Stock, which had no expiration date, automatically converted on a one-for-one basis at the closing of the Issuer's initial public offering on February 13, 2018, for no additional consideration. Shares held directly by Canaan VIII L.P. (the "Canaan Fund"). Canaan Partners VIII LLC ("Canaan VIII" and together with the Canaan Fund, the "Canaan Entities") is the sole general partner of the Canaan Fund and each may be deemed to have sole voting, investment and dispositive power with respect to the shares held by the Canaan Fund. John Balen, a manager and member of Canaan VIII, serves as the representative of the Canaan Entities on the Issuer's board of directors. Investment and voting decisions with respect to the shares held by the Canaan Fund are made by the managers of Canaan VIII, collectively. Canaan VIII disclaims Section 16 beneficial ownership of the shares held by the Canaan Fund, except to the extent, if any, of its pecuniary interest therein. EXHIBIT 99 - Joint Filer Information filed herewith and Exhibit 24 - Power of Attorney (incorporated by reference to the Power of Attorney filed as Exhibit 24 to the Form 3 filed by the Reporting Persons on February 8, 2018) Canaan VIII L.P., By: Canaan Partners VIII LLC, its general partner, By: /s/ Janine MacDonald, Attorney-in-Fact 2018-02-15 Canaan Partners VIII LLC, By: /s/ Janine MacDonald, Attorney-in-Fact 2018-02-15 EX-99 2 attachment1.htm EX-99 DOCUMENT

                                                                      EXHIBIT 99

                         FORM 4 JOINT FILER INFORMATION

            Names of Joint Filers:

            Canaan VIII L.P.
            Canaan Partners VIII LLC


            Address of Joint Filers:

            c/o Canaan Partners
            285 Riverside Avenue, Suite 250
            Westport, CT 06880

            Designated Filer:

            Canaan VIII L.P.


            Issuer and Ticker Symbol:

            Cardlytics, Inc. [CDLX]


            Date of Event:

            February 13, 2018


            Signatures of Joint Filers:

            Canaan VIII L.P.

              By: Canaan Partners VIII LLC, its General Partner

                   By: /s/ Janine MacDonald
                       --------------------------
                       Attorney-in-Fact

            Canaan Partners VIII LLC

                   By: /s/ Janine MacDonald
                       --------------------------
                       Attorney-in-Fact